Is ceramide signaling a target for vascular therapeutic intervention?

Douglas G. Johns, John R. Charpie, R Clinton Webb

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Today's society is plagued by cardiovascular diseases such as hypertension and atherosclerosis. Research devoted to the study of these diseases has focused, in part, on physiological phenomena responsible for the development and progression of the disease. Peripheral vascular function is one such focal point of research, and identification of cellular mechanisms that regulate vascular contractility and / or cellular proliferation is crucial for the development of new therapeutic interventions to combat these diseases. This review evaluates a new signaling mechanism, the ceramide signaling pathway as a potential target for therapeutic intervention. Special attention is given ceramide signaling in the contexts of vascular reactivity and cell proliferation in the vasculature. While ceramide signaling is a nascent area of vascular research, a growing body of evidence from other physiological systems implicates this new pathway as a potential regulator of contractile and cell proliferative functions within the blood vessel wall.

Original languageEnglish (US)
Pages (from-to)481-488
Number of pages8
JournalCurrent Pharmaceutical Design
Volume4
Issue number6
StatePublished - Dec 1 1998
Externally publishedYes

Fingerprint

Ceramides
Blood Vessels
Research
Cell Proliferation
Physiological Phenomena
Therapeutics
Disease Progression
Atherosclerosis
Cardiovascular Diseases
Hypertension

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Is ceramide signaling a target for vascular therapeutic intervention? / Johns, Douglas G.; Charpie, John R.; Webb, R Clinton.

In: Current Pharmaceutical Design, Vol. 4, No. 6, 01.12.1998, p. 481-488.

Research output: Contribution to journalArticle

Johns, Douglas G. ; Charpie, John R. ; Webb, R Clinton. / Is ceramide signaling a target for vascular therapeutic intervention?. In: Current Pharmaceutical Design. 1998 ; Vol. 4, No. 6. pp. 481-488.
@article{eb07edc2c0784fd6801b051cd614aca6,
title = "Is ceramide signaling a target for vascular therapeutic intervention?",
abstract = "Today's society is plagued by cardiovascular diseases such as hypertension and atherosclerosis. Research devoted to the study of these diseases has focused, in part, on physiological phenomena responsible for the development and progression of the disease. Peripheral vascular function is one such focal point of research, and identification of cellular mechanisms that regulate vascular contractility and / or cellular proliferation is crucial for the development of new therapeutic interventions to combat these diseases. This review evaluates a new signaling mechanism, the ceramide signaling pathway as a potential target for therapeutic intervention. Special attention is given ceramide signaling in the contexts of vascular reactivity and cell proliferation in the vasculature. While ceramide signaling is a nascent area of vascular research, a growing body of evidence from other physiological systems implicates this new pathway as a potential regulator of contractile and cell proliferative functions within the blood vessel wall.",
author = "Johns, {Douglas G.} and Charpie, {John R.} and Webb, {R Clinton}",
year = "1998",
month = "12",
day = "1",
language = "English (US)",
volume = "4",
pages = "481--488",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "6",

}

TY - JOUR

T1 - Is ceramide signaling a target for vascular therapeutic intervention?

AU - Johns, Douglas G.

AU - Charpie, John R.

AU - Webb, R Clinton

PY - 1998/12/1

Y1 - 1998/12/1

N2 - Today's society is plagued by cardiovascular diseases such as hypertension and atherosclerosis. Research devoted to the study of these diseases has focused, in part, on physiological phenomena responsible for the development and progression of the disease. Peripheral vascular function is one such focal point of research, and identification of cellular mechanisms that regulate vascular contractility and / or cellular proliferation is crucial for the development of new therapeutic interventions to combat these diseases. This review evaluates a new signaling mechanism, the ceramide signaling pathway as a potential target for therapeutic intervention. Special attention is given ceramide signaling in the contexts of vascular reactivity and cell proliferation in the vasculature. While ceramide signaling is a nascent area of vascular research, a growing body of evidence from other physiological systems implicates this new pathway as a potential regulator of contractile and cell proliferative functions within the blood vessel wall.

AB - Today's society is plagued by cardiovascular diseases such as hypertension and atherosclerosis. Research devoted to the study of these diseases has focused, in part, on physiological phenomena responsible for the development and progression of the disease. Peripheral vascular function is one such focal point of research, and identification of cellular mechanisms that regulate vascular contractility and / or cellular proliferation is crucial for the development of new therapeutic interventions to combat these diseases. This review evaluates a new signaling mechanism, the ceramide signaling pathway as a potential target for therapeutic intervention. Special attention is given ceramide signaling in the contexts of vascular reactivity and cell proliferation in the vasculature. While ceramide signaling is a nascent area of vascular research, a growing body of evidence from other physiological systems implicates this new pathway as a potential regulator of contractile and cell proliferative functions within the blood vessel wall.

UR - http://www.scopus.com/inward/record.url?scp=0031730655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031730655&partnerID=8YFLogxK

M3 - Article

VL - 4

SP - 481

EP - 488

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 6

ER -